PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 24, 2026Familial Cancer0 citationsOpen Access

Case report: Onychopapilloma in a patient with BAP1 tumor predisposition syndrome—a useful clinical marker?

View Full Paper
ESEmilie SjøstrømLALise Barlebo AhlbornEEElisabeth Victoria Eliesen

Key Points

  • The research aims to investigate the link between onychopapilloma and germline BAP1 variants in a patient with BAP1-TPDS.
  • Case report of a male patient diagnosed with mesothelioma and a germline BAP1 variant.
  • Observation of severe nail abnormalities affecting all fingernails and several toenails.
  • Review of literature regarding the association of onychopapilloma with BAP1 variants.
  • The patient exhibited significant nail abnormalities since adolescence, specifically onychopapilloma.
  • This is only the second reported case linking onychopapilloma to germline BAP1 variants.
  • Proposes that onychopapilloma could serve as a clinical marker for BAP1-TPDS in asymptomatic individuals.

Abstract

The BAP1 gene encodes a tumor suppressor protein implicated in BAP1 tumor predisposition syndrome (BAP1-TPDS), a hereditary condition associated with an increased risk of uveal and skin melanoma, mesothelioma, and renal cancer. In this case report, we describe a male patient diagnosed with mesothelioma carrying a germline BAP1 variant. The patient exhibited severe nail abnormalities affecting all ten fingernails and several toenails. To our knowledge, the association between onychopapilloma and pathogenic germline BAP1 variants has only been reported once in the literature. The patient had experienced nail abnormalities since adolescence. Based on these findings, we propose that polydactylous onychopapilloma may serve as a clinical marker of BAP1-TPDS in otherwise asymptomatic individuals, and could potentially aid in early identification of at-risk carriers.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sjøstrøm et al. (2026) studied this question.

synapsesocial.com/papers/69eb0a2e553a5433e34b4628https://doi.org/10.1007/s10689-026-00558-z
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome2024 · 17 citations
  2. 2A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma2012 · 117 citations
  3. 3A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma2014 · 92 citations
  4. 4Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases2013 · 110 citations
  5. 5BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization2008 · 338 citations